NeurogesX (NGSX) Reports FDA Committee will Review sNDA for Qutenza 8% Patch
Go back to NeurogesX (NGSX) Reports FDA Committee will Review sNDA for Qutenza 8% Patch| NeurogesX, Inc. (AMEX: NGSX) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $0.01 | |||
| Open | $1411.93 | 52 Week Low | $0.00 | |||
| Day High | $0.01 | P/E | N/A | |||
| Day Low | $0.01 | EPS | $-0.89 | |||
| Volume | 6,294 | |||||
